We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > teriflunomide

News List

European Commission approves PONVORY™ --- A Once Daily Oral Treatment for Adults with Relapsing Forms of Multiple Sclerosis americanpharmaceuticalreview
May 25, 2021
Janssen, the Pharmaceutical Companies of Johnson & Johnson, announced that the European Commission (EC) has approved PONVORY™ (ponesimod) for the treatment of adult patients with relapsing multiple sclerosis (RMS) with active disease defined by ...
Novartis Announces New Ofatumumab Data at EAN americanpharmaceuticalreview
June 03, 2020
Novartis announced new ofatumumab data from the Phase III ASCLEPIOS trials and the Phase II APLIOS trial were presented virtually at the 6th Congress of the European Academy of Neurology (EAN).